Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-05-13 13:00:16
Oslo, May 13, 2022 - Observe Medical ASA (OSE:OBSRV): The annual general meeting
of Observe Medical ASA will be held on Friday, June 3 2022 at 10:00 (CET).
The annual general meeting will be held at Haakon VIIs gate 2, 0161 Oslo for
those attending in person and via Lumi for those attending digitally.
Voting will be carried out electronically via Lumi both for shareholders
attending in person and attending digitally. It is also possible to vote in
advance or give proxy.
The Notice of the Annual General Meeting is attached.
The Notice is posted electronically or by mail to all shareholders and is
available on the company's website www.observemedical.com.
For further information, please contact:
Rune Nystad, CEO of Observe Medical ASA,
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO of Observe Medical ASA,
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About Observe Medical
About Observe Medical Observe Medical is a Nordic medtech company that develops,
markets and sells innovative medtech products for the global market. The Company
is committed to improving patient welfare and patient outcomes, improving
clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik
(Norway), Gothenburg (Sweden), Oulu (Finland) and Seattle (the US). In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor and partner network internationally. Further information is
available at www.observemedical.com.
This information is subject to the disclosure requirements pursuant to Section 5
-12 of the Norwegian Securities Trading Act.